Quarterly Financials | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 32 | 36 | 120 | 90 | 50 | 96 | 74 | 60 | 47 | 49 | 57 | 34 | 19 | 38 | 20 | 33 | 25 |
Expenses | 31 | 33 | 90 | 70 | 44 | 83 | 62 | 50 | 44 | 50 | 50 | 32 | 21 | 36 | 20 | 31 | 27 |
EBITDA  | 2 | 4 | 30 | 20 | 6 | 13 | 12 | 10 | 3 | -1 | 7 | 2 | -2 | 2 | -0 | 3 | -2 |
Operating Profit % | 5 % | 9 % | 25 % | 22 % | 11 % | 13 % | 16 % | 16 % | 6 % | -26 % | 12 % | 5 % | -10 % | 4 % | -9 % | 7 % | -9 % |
Depreciation | 0 | 0 | 1 | 1 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Interest | 1 | 1 | 1 | 2 | 2 | 4 | 3 | 3 | 4 | 2 | 2 | 2 | 3 | 4 | 2 | 2 | 2 |
Profit Before Tax  | 1 | 2 | 28 | 17 | 2 | 7 | 7 | 4 | -3 | -6 | 2 | -3 | -6 | -4 | -4 | -1 | -6 |
Tax | 0 | 1 | 8 | 4 | 1 | 2 | 3 | 2 | -1 | -1 | 1 | -0 | -0 | -0 | -1 | 1 | -1 |
Net Profit | 0 | 1 | 20 | 13 | 1 | 5 | 4 | 3 | -2 | -5 | 2 | -2 | -6 | -4 | -3 | -2 | -5 |
EPS in ₹ | 0.42 | 2.30 | 38.66 | 12.41 | 1.29 | 5.16 | 3.99 | 2.20 | -1.36 | -3.63 | 1.41 | -1.74 | -4.52 | -2.75 | -2.35 | -1.53 | -3.98 |
Above figures are in Rs. Crores Balance Sheet | 2022 | 2023 | 2024 |
Total Assets  | 291 | 278 | 242 |
Fixed Assets | 93 | 88 | 58 |
Current Assets | 193 | 183 | 173 |
Capital Work in Progress | 0 | 0 | 0 |
Investments | 0 | 0 | 0 |
Other Assets | 198 | 190 | 184 |
Total Liabilities  | 291 | 278 | 242 |
Current Liabilities | 166 | 162 | 145 |
Non Current Liabilities | 41 | 29 | 22 |
Total Equity  | 84 | 86 | 76 |
Reserve & Surplus | 69 | 69 | 59 |
Share Capital | 10 | 13 | 13 |
Above figures are in Rs. Crores Cash Flow | 2022 | 2023 | 2024 |
Net Cash Flow | 0 | 0 | 0 |
Investing Activities | -44 | -9 | 20 |
Operating Activities | 25 | 26 | -10 |
Financing Activities | 20 | -17 | -10 |
Above figures are in Rs. Crores % Holding | Mar 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Promoter | 71.01 % | 71.07 % | 71.09 % | 71.14 % | 71.15 % | 71.15 % | 71.15 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % |
FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
Public / Retail | 19.94 % | 25.53 % | 26.62 % | 25.87 % | 25.66 % | 25.76 % | 25.56 % | 26.13 % | 26.23 % | 26.09 % | 25.29 % | 25.62 % | 25.48 % | 25.45 % | 25.92 % | 26.11 % |
Others | 9.05 % | 3.40 % | 2.29 % | 2.99 % | 3.20 % | 3.09 % | 3.30 % | 3.27 % | 3.16 % | 3.31 % | 4.11 % | 3.78 % | 3.92 % | 3.95 % | 3.48 % | 3.29 % |
No of Share Holders | 0 | 328 | 323 | 2,522 | 4,259 | 5,215 | 6,939 | 7,163 | 7,305 | 7,055 | 6,918 | 6,868 | 6,631 | 6,468 | 6,517 | 6,508 |
Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 0.00 | 0.00 | 0.00 |
Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.33 | 0.00 | 0.00 | 0.00 |
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Disclosure Of Non-Applicability Of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November 2018- Fund Raising By Issuance Of Debt Securities By Large Corporate (LC)
22 hours ago Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
22 hours ago Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
2 days ago Closure of Trading Window
Apr 01, 2025 Closure of Trading Window
Apr 01, 2025 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Mar 20, 2025 Appointment of Company Secretary and Compliance Officer
Mar 12, 2025 Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 15, 2025 Integrated Filing (Financial)
Feb 14, 2025 UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024
Feb 14, 2025 Board Meeting Outcome for Board Meeting Outcome For SUBMISSION OF UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024
Feb 14, 2025 Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Declaring Unaudited Standalone & Consolidated Financial Results For The Quarter And Nine Months Ended December 31
Feb 06, 2025 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 14, 2025 Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Dec 16, 2024 Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 16, 2024 Financial Results For Quarter And Half Year Ended 30.09.2024.
Nov 14, 2024 Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.11.2024
Nov 14, 2024 Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
Nov 07, 2024 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 15, 2024 Scrutinizer Report And Evoting Result For AGM 30.09.2024 Of ANG Lifesciences India Limited
Oct 02, 2024 Disclosure under Regulation 30A of LODR
Oct 01, 2024 Shareholder Meeting / Postal Ballot-Outcome of AGM
Oct 01, 2024 Closure of Trading Window
Sep 25, 2024 Reg. 34 (1) Annual Report.
Sep 07, 2024 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Sep 07, 2024 Book Closure For 18Th Annual General Meeting
Sep 07, 2024 Notice Of AGM For FY 2023-24
Sep 07, 2024 Unaudited Standalone And Consolidated Financial Result For Quarter Ended As At 30.06.2024
Aug 14, 2024 Board Meeting Outcome for Outcome Of Board Meeting Dated 14.08.2024
Aug 14, 2024 Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
Aug 14, 2024 Board Meeting Intimation for Notice Of Board Meeting Under Reg. 29Of SEBI (LODR), 2015
Aug 07, 2024 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Jul 17, 2024 Closure of Trading Window
Jun 29, 2024 Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015.
Jun 27, 2024 Announcement under Regulation 30 (LODR)-Newspaper Publication
Jun 13, 2024 Announcement under Regulation 30 (LODR)-Cessation
Jun 13, 2024 Compliances-Reg.24(A)-Annual Secretarial Compliance
May 30, 2024 Financial Result For Quarter And Year Ended As At 31.03.2024
May 30, 2024 Board Meeting Outcome for Outcome Of Board Meeting
May 30, 2024 Announcement under Regulation 30 (LODR)-Meeting Updates
May 27, 2024 Board Meeting Intimation for Approval Of Audited Financial Standalone And Consolidated Statements For Quarter And Year Ended 31.03.2024.
May 24, 2024 Announcement under Regulation 30 (LODR)-Meeting Updates
May 13, 2024 Disclosure And Intimation Of Non-Applicability Of SEBI Circular No SEBI/HO/DDHS/Clr/P /2018/744 Dated November 26, 2018 With Respect To Fund Raising By Issuance Of Debt Securities By Large Entities.
Apr 30, 2024 Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Apr 30, 2024 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Apr 20, 2024 Compliance Certificate For The Year Ended 31.03.2024
Apr 20, 2024 Clarification On Price Movement
Apr 10, 2024 Clarification sought from ANG Lifesciences India Ltd
Apr 09, 2024 Closure of Trading Window
Mar 30, 2024 Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 16, 2024 RSI(14)

Neutral
46.40
ATR(14)

Less Volatile
2.08
STOCH(9,6)

Neutral
47.56
STOCH RSI(14)

Neutral
77.39
MACD(12,26)

Bullish
0.48
ADX(14)

Strong Trend
28.12
UO(9)

Bearish
45.21
ROC(12)

Uptrend And Accelerating
5.40
WillR(14)

Neutral
-43.19